Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 54, Issue 5, Pages 1578-1582
Publisher
Wiley
Online
2014-12-12
DOI
10.1002/anie.201410456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase
- (2014) Alessio De Simone et al. CHEMICAL COMMUNICATIONS
- Lessons Learnt from Glycogen Synthase Kinase 3 Inhibitors Development for Alzheimer’s Disease
- (2014) Ana Martinez et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents
- (2014) Elisabet Viayna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes
- (2012) Antonio Contestabile et al. Current Neuropharmacology
- 5-Imino-1,2,4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3
- (2012) Valle Palomo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Review: Activation patterns of microglia and their identification in the human brain
- (2012) D. Boche et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Beta-secretase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors
- (2011) Francesca Mancini et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- The role of fragment-based and computational methods in polypharmacology
- (2011) Giovanni Bottegoni et al. DRUG DISCOVERY TODAY
- Neuroinflammation: Modulation by flavonoids and mechanisms of action
- (2011) Jeremy P.E. Spencer et al. MOLECULAR ASPECTS OF MEDICINE
- Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors
- (2010) Jesús Avila et al. Expert Review of Neurotherapeutics
- Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
- (2010) Lauren Broom et al. FREE RADICAL BIOLOGY AND MEDICINE
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells
- (2010) Christian Lange et al. NEUROSCIENCE LETTERS
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
- (2008) Christopher J. Yuskaitis et al. CELLULAR SIGNALLING
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search